Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion cash
Cash and short-term investments held at the end of each period.
Biomea Fusion's cash was $26.40M at Sep 30, 2026. For fiscal 2025 it was $55.81M, down 4.8% from the year before. The highest annual figure on record is $176.87M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.81M | -4.8% |
| FY2024 | Dec 31, 2024 | $58.65M | -66.8% |
| FY2023 | Dec 31, 2023 | $176.87M | +56.0% |
| FY2022 | Dec 31, 2022 | $113.40M | -34.8% |
| FY2021 | Dec 31, 2021 | $173.87M | +181.8% |
| FY2020 | Dec 31, 2020 | $61.70M | +25713.8% |
| FY2019 | Dec 31, 2019 | $239.00K | +206.4% |
| FY2018 | Dec 31, 2018 | $78.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $26.40M | -43.4% |
| Q2 FY2026 | Jun 30, 2026 | $34.82M | -38.1% |
| Q1 FY2026 | Mar 31, 2026 | $44.69M | +24.6% |
| Q4 FY2025 | Dec 31, 2025 | $55.81M | -4.8% |
| Q3 FY2025 | Sep 30, 2025 | $46.64M | -47.0% |
| Q2 FY2025 | Jun 30, 2025 | $56.22M | -50.4% |
| Q1 FY2025 | Mar 31, 2025 | $35.86M | -75.3% |
| Q4 FY2024 | Dec 31, 2024 | $58.65M | -66.8% |
| Q3 FY2024 | Sep 30, 2024 | $87.95M | -55.8% |
| Q2 FY2024 | Jun 30, 2024 | $113.29M | -49.2% |
| Q1 FY2024 | Mar 31, 2024 | $144.92M | +67.9% |
| Q4 FY2023 | Dec 31, 2023 | $176.87M | +56.0% |
| Q3 FY2023 | Sep 30, 2023 | $199.09M | +49.2% |
| Q2 FY2023 | Jun 30, 2023 | $222.91M | +49.0% |
| Q1 FY2023 | Mar 31, 2023 | $86.30M | -47.6% |
| Q4 FY2022 | Dec 31, 2022 | $113.40M | -34.8% |
| Q3 FY2022 | Sep 30, 2022 | $133.46M | -29.5% |
| Q2 FY2022 | Jun 30, 2022 | $149.63M | -24.6% |
| Q1 FY2022 | Mar 31, 2022 | $164.81M | +262.4% |
| Q4 FY2021 | Dec 31, 2021 | $173.87M | +181.8% |
| Q3 FY2021 | Sep 30, 2021 | $189.41M | +2243.5% |
| Q2 FY2021 | Jun 30, 2021 | $198.57M | +2059.3% |
| Q1 FY2021 | Mar 31, 2021 | $45.48M | +122810.8% |
| Q4 FY2020 | Dec 31, 2020 | $61.70M | +25713.8% |
| Q3 FY2020 | Sep 30, 2020 | $8.08M | +10261.5% |
| Q2 FY2020 | Jun 30, 2020 | $9.20M | – |
| Q1 FY2020 | Mar 31, 2020 | $37.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $239.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $78.00K | – |
See a number that looks wrong?